Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Soheil Ghasemi"'
Autor:
Akram Ansarifar, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, Mohammadreza Ahi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Fatemeh Gholami, Pouria Basiri, Milad Moradi, Arash Jahangiri, Kosar Naderi, Soheil Ghasemi, Pezhman Khatami, Mohsen Honari, Samane Khodaverdloo, Mohammad Shooshtari, Hajar Mehr Azin, Sohrab Moradi, Batool Shafaghi, Hossein Allahyari, Arina Monazah, Ali Khodaei Poor, Hooman Bakhshande, Zahra Taghva, Mohammad Karimi Nia, Masoud Solaymani Dodaran, Mohsen Foroughizadeh
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100401- (2023)
Background: The FAKHRAVAC®, an inactivated SARS-CoV-2 vaccine, was assessed for safety and immunogenicity. Methods and findings: In this double-blind, placebo-controlled, phase I trial, we randomly assigned 135 healthy adults between 18 and 55 to re
Externí odkaz:
https://doaj.org/article/c2f803c6133047028466ef7f156982f4
Autor:
Masoud Solaymani-Dodaran, Pouria Basiri, Milad Moradi, Kimiya Gohari, Ali Sheidaei, Mohammadreza Ahi, Farzad Ghafoori Naeeni, Akram Ansarifar, Zahra Rahimi, Fatemeh Gholami, Ahmad Karimi Rahjerdi, Ramin Hamidi Farahani, Kosar Naderi saffar, Soheil Ghasemi, Ali Shooshtari, Mohsen Honari, Ali Mozafari, Samane Khodaverdloo, Mohsen Forooghizadeh
Publikováno v:
Virology Journal, Vol 20, Iss 1, Pp 1-11 (2023)
Abstract Background We compared Fakhravac and BBIBP-Corv2 vaccines in a phase III trial. Method We conducted a multicenter, parallel-group, active-control, non-inferiority clinical trial with pragmatic considerations assessing the safety and efficacy
Externí odkaz:
https://doaj.org/article/5c23619ff3214f14a8dca1f12a65f2d1
Autor:
Fatemeh Gholami, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, Mohammadreza Ahi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Akram Ansarifar, Pouria Basiri, Milad Moradi, Arash Jahangiri, Kosar Naderi, Soheil Ghasemi, Pezhman Khatami, Mohsen Honari, Samane Khodaverdloo, Mohammad Shooshtari, Hajar Mehr Azin, Sohrab Moradi, Batool Shafaghi, Hossein Allahyari, Arina Monazah, Ali Khodaei Poor, Zahra Taghva, Hooman Bakhshande, Mohammad Karimi Nia, Masoud Solaymani Dodaran, Mohsen Forooghizade
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background The FAKHRAVAC®, an inactivated SARS-CoV-2 vaccine, was assessed for safety and immunogenicity in a phase II trial. Methods We did a phase II, single-centered, randomized, double-blind, placebo-controlled clinical trial of the FAK
Externí odkaz:
https://doaj.org/article/7cff59226f404594bc909b45886fb632
Autor:
Mojtaba Ghasemiadl, Soheil Ghasemi, Alireza Soleimani, Mahsa M. Esfahani, Javid Azadbakht, Hamid R. Gilasi, Hamid R. Talari
Publikováno v:
International Journal of Preventive Medicine, Vol 15, Iss 1, Pp 6-6 (2024)
Background: Prior studies have reported that curcumin is inversely associated with reduced markers of atherosclerosis risk, including carotid intima-media thickness (CIMT). This study was designed to assess the effects of curcumin on CIMT and pulse w
Externí odkaz:
https://doaj.org/article/4d849e37aa23408196558093b2de97d6
Autor:
Mohammadreza Ahi, Ramin Hamidi Farahani, Pouria Basiri, Ahmad Karimi Rahjerdi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Fatemeh Gholami, Milad Moradi, Farzad Ghafoori Naeeni, Kosar Naderi Saffar, Soheil Ghasemi, Babak Barati, Sohrab Moradi, Arina Monazah, Fatemeh Pouranvari, Mohsen Forooghizadeh
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1800 (2022)
Purpose: This study was completed to assess the immunogenicity and safety of the FAKHRAVAC and BBIBP-CorV vaccines as a booster dose in the population with a history of receiving two doses of BBIBP-CorV vaccine. Methods: In this double-blind, paralle
Externí odkaz:
https://doaj.org/article/7b22729b86374dafb54293d609b7cd6a
Autor:
Soheil Ghasemi, Kosar Naderi Saffar, Firooz Ebrahimi, Pezhman Khatami, Arina Monazah, Ghorban-Ali Alizadeh, Hossein-Ali Ettehadi, Iman Rad, Shahrzad Nojehdehi, Mousa Kehtari, Fatemeh Kouhkan, Hesam Barjasteh, Sohrab Moradi, Mohammad-Hosein Ghorbani, Ali Khodaeipour, Moslem Papizadeh, Roghayeh Najafi, Ehsan Naghneh, Davood Sadeghi, Ahmad Karimi Rahjerdi
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1271 (2021)
The recent viral infection disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global public health crisis. Iran, as one of the countries that reported over five million infected cases by Septem
Externí odkaz:
https://doaj.org/article/4029ad1958be4e4ea152650fa4f5f074
Autor:
Masood Solaymani-dodaran, Pouria Basiri, Milad Moradi, Kimiya Gohari, Ali Sheidaei, Mohammadreza Ahi, Akram Ansarifar, Zahra Rahimi, Fatemeh Gholami, Ahmad karimi Rahjerdi, Ramin Hamidi Farahani, Kosar Naderi saffar, Soheil Ghasemi, Ali Shooshtari, Mohsen Honari, Ali Mozafari, Samane Khodaverdloo, Mohsen Forooghizadeh
Publikováno v:
SSRN Electronic Journal.
Autor:
Ahmad Karimi Rahjerdi, Davood Sadeghi, Ghorban-Ali Alizadeh, Iman Rad, Ali Khodaie, Hesam Barjasteh, Fatemeh Kouhkan, Shahrzad Nojehdehi, Soheil Ghasemi, Kosar Naderi Saffar, Pezhman Khatami, Mohammad-Hosein Ghorbani, Moslem Papizadeh, Ehsan Naghneh, Hossein-Ali Ettehadi, Roghayeh Najafi, Mousa Kehtari, Sohrab Moradi, Firooz Ebrahimi, Arina Monazah
Publikováno v:
Vaccines; Volume 9; Issue 11; Pages: 1271
Vaccines, Vol 9, Iss 1271, p 1271 (2021)
Vaccines, Vol 9, Iss 1271, p 1271 (2021)
The recent viral infection disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global public health crisis. Iran, as one of the countries that reported over five million infected cases by Septem
Synthesis and In vitro Cytotoxicity of a Novel Efficient Cisplatin-loaded poly N-butyl cyanoacrylate
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 50:190-197
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.